We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Clostridium difficile infections in Finland, 2008-2015: trends, diagnostics and ribotypes.
- Authors
Mentula, S.; Kotila, S.; Lyytikäinen, O.; Ibrahem, S.; Ollgren, J.; Virolainen, A.
- Abstract
We evaluated Clostridium difficile (CD) diagnostics in Finnish clinical microbiology laboratories during 2006-2011, with an update in 2015, in relation to CD surveillance data of the National Infectious Disease Register (NIDR) and ribotyping data from the national reference laboratory during the years 2008-2015. In 2011, diagnostic activity varied regionally more than three-fold and the positivity rate ranged between 7 and 21%. Nucleic acid amplification testing (NAAT) was implemented in the regions with high activity and NAAT users tested 30% more patients and found 15% more cases per population than those not using it. Culture was performed in 79% of laboratories, primary toxin testing by enzyme immunoassay (EIA) in 83% and by NAAT in 17%. In 2014, 12/19 laboratories used NAAT as the primary detection method and four as the secondary method, and ten cultured. Increasing usage of NAAT was not systematically related to various trends detected regionally in annual CD rates. Polymerase chain reaction (PCR) ribotyping of 1771 CD isolates (4.1% of CD cases) identified 146 distinct profiles, of which 37% were binary toxin positive. The most common ribotype was 027, but its proportion decreased, while 078 slightly increased. Transition from culture to NAAT in CD infection (CDI) diagnostics did not cause a significant increase in the observed CDI incidence. Major differences between diagnostic activity, methods and strategies in different regions have persisted over the years, which should be considered when comparing the regional epidemiology of CDI.
- Subjects
CLOSTRIDIOIDES difficile; DIARRHEA; PUBLIC health; ANTI-infective agents; INTESTINAL diseases
- Publication
European Journal of Clinical Microbiology & Infectious Diseases, 2017, Vol 36, Issue 10, p1939
- ISSN
0934-9723
- Publication type
Article
- DOI
10.1007/s10096-017-3017-5